Search Results - Mark Parta
- Showing 1 - 2 results of 2
-
1
Human papillomavirus disease in GATA2 deficiency: a genetic predisposition to HPV-associated female anogenital malignancy by Ehren Dancy, Ehren Dancy, Pamela Stratton, Dominique C. Pichard, Beatriz E. Marciano, Edward W. Cowen, Alison A. McBride, Koenraad Van Doorslaer, Koenraad Van Doorslaer, Melissa A. Merideth, Noemi Salmeri, Noemi Salmeri, Marybeth S. Hughes, Theo Heller, Mark Parta, Dennis D. Hickstein, Heidi H. Kong, Steven M. Holland, Christa S. Zerbe
Published in Frontiers in Immunology (2024-08-01)Get full text
Article -
2
Intermediate-dose posttransplantation cyclophosphamide for myeloablative HLA-haploidentical bone marrow transplantation by Mustafa A. Hyder, Dimana Dimitrova, Ruby Sabina, Ashley DeVries, Jeannine S. McCune, Meredith J. McAdams, Francis A. Flomerfelt, Christi McKeown, Jennifer L. Sadler, Amy Chai, Thomas E. Hughes, Scott Napier, Anita Stokes, Jennifer Sponaugle, Kamil Rechache, Mark Parta, Jennifer Cuellar-Rodriguez, William D. Figg, Hyoyoung Choo-Wosoba, Seth M. Steinberg, Jennifer A. Kanakry, Christopher G. Kanakry
Published in Blood Advances (2025-05-01)Get full text
Article
